2
Participants
Start Date
April 27, 2021
Primary Completion Date
February 10, 2022
Study Completion Date
February 10, 2022
NEX-18a injection
"In Treatment phase 1, NEX-18a will be given as a single subcutaneous injection.~In Treatment phase 2, NEX-18a will be given as a single subcutaneous injection."
Azacitidine Injection
In Treatment phase 1, azacitidine will be administered once daily for four days. In Treatment phase 2, azacitidine will be administered once daily for three days.
Karolinska University Hospital Huddinge, Huddinge
Kliniska Forsknings och Utvecklings Enheten KFUE, Uppsala
Lead Sponsor
Uppsala University
OTHER
Nanexa AB
INDUSTRY